5th ICHNO Programme Book

16:10 Pivotal trial results and EU comparison of 99mTc-Tilmanocept in sentinel node biopsy in head and neck cancer patients R. De Bree (The Netherlands), J. Buscombe, S.Y. Lai, A. Agrawal, C. Reininger, F. Civantos 16:20 Definitive chemoradiotherapy: An alternative to surgery in stage III/IV squamous cell carcinoma of the oral cavity? M.H. Bertke (USA), N.E. Dunlap, M.J. Amsbaugh, C.L. Silverman, J.M. Bumpous, K.L. Potts, R.A. Redman, J.N. Shaughnessy 16:30 Morbidity and functional outcomes of different transoral supraglottic resections C. Piazza (Italy), F. Del Bon, D. Barbieri, P. Grazioli, P. Perotti, A. Paderno, G. Mazza, B. Frittoli, P. Nicolai, G. Peretti 16:40 ‘Cure’ is a realistic goal in HPV-related oropharyngeal cancer with oligometastasis S. Huang (Canada), J. Waldron, W. Xu, J. Ringash, A. Bayley, A. Hope, J. Kim, J. Cho, M. Giuliani, B. O’Sullivan 16:50 Best practices for supportive care during chemo-radiotherapy in head and neck cancer patients P. Bossi (Italy), E. Russi, G. Numico, J.B. Vermorken, B. Murphy, J. Raber-Durlacher, J.A. Langendijk, C. Rognoni, S. Quaglini, L. Licitra Debate THIS HOUSE BELIEVES THAT RADIOTHERAPY SHOULD BE COMBINED WITH CETUXIMAB BUT NOTWITH CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED HPV POSITIVE OROPHARYGEAL CANCER 17:00 - 18:00 Chair: J. Bourhis (Switzerland) 17:00 For the motion Speaker: K. Harrington (United Kingdom) 17:15 Against the motion Speaker: J. Overgaard (Denmark)

OC-041

OC-042

OC-043

OC-044

OC-045

PROGRAMME & EXHIBITION GUIDE | SCIENTIFIC PROGRAMME

19